2110 Richmond Road Staten Island, NY 10306
Tel: 718-351-7363 Toll Free:1-844-994-0016
OSTEOPOROSIS IS A CONDITION CAUSING BRITTLENESS AND WEAKNESS OF THE BONES.
Osteoporosis, or thinning bones, can result in painful fractures. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications.
A person is often not aware that he or she has osteoporosis until a fracture occurs. But there are occasionally symptoms of the disorder, which could include:
A gradual loss of height and an accompanying stooped posture.
Fractures of the spine, wrist, or hip.
TYMLOS is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.
FORTEO is used to treat Osteoporosis in both women and men at a high risk of bone fractures. It works by increasing new bone formation by stimulating the cells that create bone mass.
PROLIA is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture and other osteoporosis medicines did not work well. It works by decreasing the activity of the cells in bone that cause resorption and recycling of the bone.
RECLAST (ZOLEDRONIC ACID) is indicated for the treatment of osteoporosis in postmenopausal women. Zoledronic Acid reduces the incidence of fractures. Zoledronic Acid is used to increase bone mass in men with osteoporosis. It works by decreasing the activity of the cells in bone that cause resorption and recycling of the bone.
Osteoporosis treatments include the “basic CDE’s” -- calcium(C), vitamin D (D), weight-bearing exercise (E), prevention of Falls (F), and bone-friendly medicines.